A natural protective function of invariant NKT cells in a mouse model of innate-cell-driven lung inflammation
✍ Scribed by Elvire A. Bourgeois; Anaïs Levescot; Séverine Diem; Angélique Chauvineau; Hortense Bergès; Pierre Milpied; Agnès Lehuen; Diane Damotte; Jean-Marc Gombert; Elke Schneider; Jean-Philippe Girard; Pierre Gourdy; André Herbelin
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 258 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
✦ Synopsis
Activation of invariant natural killer T (iNKT) cells by treatment with their a-galactosyl ceramide ligand provides therapeutic benefits in several immune inflammatory settings. Given the artificial nature of this stimulation, the natural regulatory functions of iNKT remain uncertain. Addressing this issue in a mouse model of innate-cell-driven lung inflammation induced by the cytokine/alarmin IL-33 that targets iNKT cells, we found that eosinophil and neutrophil recruitment was markedly increased in treated iNKT cell-deficient (Ja18 KO) mice, as was the local production of eotaxin and keratinocyte chemoattractant chemokines. By contrast, lung inflammation decreased after adoptive transfer of iNKT cells, which restored the WT inflammatory response in Ja18 KO mice. Finally, we established that this natural anti-inflammatory function of iNKT cells depends on their IFN-c production and on endogenous IL-12. Our study provides the first evidence of a protective role of iNKT cells during lung inflammation that does not require pharmacological TCR engagement.
📜 SIMILAR VOLUMES
## Abstract We have investigated the role of the host's CD1d‐dependent innate antitumor immune response in a murine T‐cell lymphoma model __in vivo.__ We found that C57BL/6 wildtype (WT) mice inoculated with RMA/S cells transfected with murine CD1d1 died at the same rate as mice inoculated with vec
The present study was done to delineate cause-effect relationships between the ethanol (EtOH)-induced stress response, natural-killer (NK)-cell activity, and resistance to experimental metastases of B16F10 melanoma cells in mice. Increased numbers of metastatic nodules were noted in the lungs of mic
## Abstract The combination therapy of CPT‐11, a prodrug of SN‐38, with S‐1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, shows a high clinical response rate in non‐small cell lung cancer (NSCLC). However, this combination causes severe toxicities such as diarrhea. Here, we invest